LONDON MARKET CLOSE: Stocks close out rollercoaster week with losses Read More
CORRECT: Oxford BioMedica to acquire 80% ownership of new US business Read More
LONDON MARKET MIDDAY: Stocks sink on Ukraine tensions and hawkish Fed Read More
Oxford BioMedica to acquire 80% ownership of new US virus business Read More
Oxford Biomedica starts search for new CEO as Dawson steps down Read More
Oxford Biomedica wins new agreement for LentiVector platform Read More
LONDON BROKER RATINGS: BofA starts Pod Point at Buy; Barclays cuts DCC Read More
Oxford Biomedica in license and supply deals with Novartis and Arcellx Read More
Oxford BioMedica licences technology for cystic fibrosis treatment Read More
LONDON BROKER RATINGS: Keppler Cheuvreux raises Pearson to Hold Read More
LONDON BROKER RATINGS: Investec prefers 888 over Entain Read More
LONDON MARKET CLOSE: Stocks up as Evergrande fears soothed before Fed Read More
TOP NEWS: Oxford BioMedica sales double; Serum Institute buys stake Read More
UK earnings, trading statements calendar - next 7 days Read More
ReNeuron taps Oxford Biomedica executive Catherine Isted as CFO Read More
EXECUTIVE CHANGES: Oxford BioMedica adds former Teva exec to board Read More
BROKER RATINGS: Citigroup prefers Beazley over Hiscox and Lancashire Read More
IN BRIEF: Oxford BioMedica exec sells shares after options exercise Read More
BROKER RATINGS: Deutsche raises GSK; HSBC cuts BP to Hold Read More
BROKER RATINGS: UBS cuts Rio Tinto to Sell; Morgan Stanley ups Ocado Read More
